EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

PRP or not PRP: Is the debate surrounding platelets‐based blood‐derived products evolving?

Enrico Ragni, Michela Maria Taiana, Tomislav Čengić, Laura de Girolamo, Marko Ostojić

Knee Surgery, Sports Traumatology, Arthroscopy · 2025-05 · 33 (5) · 1920-1924

DOI: 10.1002/ksa.12655 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Knee Surgery, Sports Traumatology, Arthroscopy, online erschienen am 13.03.2025. Verfasst von Enrico Ragni und 4 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Ospedale Galeazzi - Sant'Ambrogio, Laboratorio di Biotecnologie Applicate all'Ortopedia, Milano, Italy. Hauptthemen laut MEDLINE: Platelet-Rich Plasma. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union-Next Generation EU-NRRP M6C2-Investment 2.1 Enhancement and strengthening of biomedical research in the NHS (Project Code PNRR-MCNT2-2023-123778….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing interest in biologic treatments for musculoskeletal disorders has led to the advancement of orthobiologics, particularly in non‐operative care through injectable therapies. However, defining these treatments clearly is crucial for proper clinical application. Orthobiologics include biologic substances that enhance healing, such as cell‐based therapies and blood‐derived products. Among these, platelet‐rich plasma (PRP) is widely used, but its classification remains complex due to variations in preparation methods, platelet concentration, leucocyte content, and activation techniques. Strictly, the term ‘PRP’ refers to plasma enriched in platelets relative to baseline blood levels. Yet, scientific debate persists regarding whether platelet count or enrichment is more significant in clinical outcomes. Additionally, leucocyte‐rich and leucocyte‐poor PRPs offer different therapeutic advantages depending on the target tissue, complicating standardization. Similarly, the presence of red blood cells is generally discouraged, given their association with joint inflammation. Beyond the classical ‘PRP’ formulations, alternative blood‐derived products offer distinct biological effects. A standardized classification system is therefore essential for research and clinical application, emphasizing precise documentation of products' characteristics, including platelet count, activation state and bioactive molecule interactions. Understanding these variables and their impact on patient‐specific conditions will refine orthopaedic regenerative strategies and optimize treatment efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet-Rich PlasmaHumansPlatelet CountBlood Platelets

Autor:innen und Institutionen

  • IRCCS Ospedale Galeazzi - Sant'Ambrogio, Laboratorio di Biotecnologie Applicate all'Ortopedia, Milano, Italy.
  • Geriatric Traumatology and Hip Surgery Division, Traumatology Department 'Draskoviceva', University Hospital 'Sestre Milosrdnice', Zagreb, Croatia.
  • Sports Traumatology Division, Traumatology Department 'Draskoviceva', University Hospital 'Sestre Milosrdnice', Zagreb, Croatia.
  • Osteon Orthopedics Trauma and Sports Medicine Clinic, Mostar, Bosnia and Herzegovina.
  • European Society of Sports Traumatology, Knee Surgery and Arthroscopy (ESSKA) Basic Science Committee, Luxembourg, Luxembourg.

Förderung

  • European Union-Next Generation EU-NRRP M6C2-Investment 2.1 Enhancement and strengthening of biomedical research in the NHS (Project Code PNRR-MCNT2-2023-123778…

Zitieren

APA

Ragni, E., Taiana, M. M., Čengić, T., de Girolamo, L., & Ostojić, M. (2025). PRP or not PRP: Is the debate surrounding platelets‐based blood‐derived products evolving?. Knee Surgery, Sports Traumatology, Arthroscopy, 33(5), 1920-1924. https://doi.org/10.1002/ksa.12655

Vancouver

Ragni E, Taiana MM, Čengić T, de Girolamo L, Ostojić M. PRP or not PRP: Is the debate surrounding platelets‐based blood‐derived products evolving?. Knee Surgery, Sports Traumatology, Arthroscopy. 2025;33(5):1920-1924. doi:10.1002/ksa.12655

BibTeX
@article{Ragni2025,
  author = {Ragni, Enrico and Taiana, Michela Maria and Čengić, Tomislav and de Girolamo, Laura and Ostojić, Marko},
  title = {PRP or not PRP: Is the debate surrounding platelets‐based blood‐derived products evolving?},
  journal = {Knee Surgery, Sports Traumatology, Arthroscopy},
  year = {2025},
  volume = {33},
  number = {5},
  pages = {1920--1924},
  doi = {10.1002/ksa.12655}
}
Kostenlos starten →